Bevacizumab Plus Erlotinib in Chinese Patients with Untreated, EGFR-Mutated, Advanced NSCLC (ARTEMIS-CTONG1509): A Multicenter Phase 3 Study
暂无分享，去创建一个
Ying Cheng | Yi-long Wu | Zhi-yong Ma | Yunpeng Liu | Xiao-Ling Li | Shiying Yu | Y. Shu | N. Yang | Cheng Huang | Gong-yan Chen | Shun Lu | Jianying Zhou | J. Cui | Yong Song | Qing Zhou | S. Lu | Gongyan Chen